New painkiller aims to cut opioid use after abdominal surgery

NCT ID NCT06737341

First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 27 times

Summary

This study tests whether a long-acting numbing drug (bupivacaine liposomes) can reduce pain and the need for opioid painkillers after laparoscopic liver, gallbladder, or pancreas surgery. About 60 adults will receive either the long-acting drug mixed with a standard numbing drug or the standard drug alone, injected near the ribs. The goal is to see if the newer drug provides better pain control for up to 72 hours after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BUPIVACAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. 1095 Jiefang Avenue, Wuhan City, Hubei Province

    Wuhan, Hubei, 430030, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.